This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: ABT AMZN CROX DF TRIP

Sprint (S) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $9.25. Stock has pulled back to an attractive level, Deutsche Bank said.

TripAdvisor (TRIP - Get Report) was upgraded at RBC to outperform from underperform. Twelve-month price target is $95. Company should begin to see accelerating growth in click-based advertising revenue, RBC said.

Veeco (VECO) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $50. Order outlook is improving, Credit Suisse said.

Stock Comments / EPS Changes

Conagra (CAG) estimates, price target were reduced at Credit Suisse. Shares are now seen reaching $31. Estimates were also cut, following the company's latest profit warning, Credit Suisse said. Neutral rating.

ConAgra Foods (CAG) price target, EPS estimates were cut at Jefferies. All operating segments are under pressure, and management lowered guideance, Jefferies said. Twelve-month price target is $35. Buy rating.

Must Read: Analysts' Actions: AXP BMY DO JPM STJ

CNO Financial (CNO) price target, EPS estimates were lifted at UBS. Strong fourth-quarter results and closed block LTC reinsurance deal should drive upside, UBS said. Twelve-month price target is now $19. Neutral rating.

Fossil (FOSL) estimates, price target were increased at Sterne Agee. Estimates were boosted through 2015. Company is seeing higher wholesale demand in North America, Sterne Agee said. Twelve-month price target is now $132.

International Exchange (ICE) numbers were increased at BMO Capital. Estimates were boosted through 2015. Company is cutting costs, BMO Capital said. Outperform rating and new 12-month price target of $230.

Eli Lilly (LLY) price target increased at Jefferies. Strong performance in Cymbalta, Humalog, Alimta and Cialis, Jefferies said. Twelve-month price target is $44. Underperform rating.

Sprint (S) price target, EPS estimates were raised at UBS. Tablets were a big driver of subscriber growth in the fourth quarter. Twelve-month price target is $8. Neutral rating.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AMZN $671.00 -0.05%
TRIP $59.75 -9.20%
AAPL $94.30 -0.92%
FB $118.08 0.55%
GOOG $695.81 0.50%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs